Triplet Induction + 1 or 2-Drug Maintenance
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance
Near Add Your Location
Sorting 370 by
Mayo Clinic (Rochester)
Rochester, MN
- Accepting patients
Cancer Care Center of O'Fallon
O'Fallon, IL
- Accepting patients
St. Luke's Cancer Institute - Boise
Boise, ID
- Accepting patients
- Accepting patients
- Accepting patients
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Not yet accepting
Capital Region Medical Center (Goldschmidt Cancer Center)
Jefferson City, MO
- Accepting patients
Spectrum Health Reed City Hospital
Reed City, MI
- Accepting patients
Centura Mercy Hospital
Durango, CO
- Accepting patients
Illinois CancerCare (Carthage)
Carthage, IL
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.